What adjuvant therapy would you offer for a cisplatin-eligible patient with upper tract urothelial carcinoma and Lynch Syndrome?
Would T or N group change your recommendation?
Community PollStarted
In a cisplatin-eligible patient with upper tract urothelial carcinoma and Lynch Syndrome, what adjuvant therapy would you offer?
27 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Washington School of Medicine
Answered on
Good question and discussed it with Dr. @Dr. First Last. We have seen data from the POUT phase 3 trial (Birtle et al., PMID 32145825) showing significant DFS benefit with adjuvant Gem/Cis vs observation after radical surgery (due to study closure the trial was not powered to show OS benefit) in pati...
Join for free or sign in to see the full answer